Abstract:Background: Whether the endocrine aberrations caused by polycystic ovary syndrome (PCOS) might influence bone density in women of reproductive age is controversial. Objectives: The present study aimed to compare PCOS women to a control group matched in terms of age and body mass index (BMI) regarding bone indices and to clarify the potential relationship between their hormonal changes and bone density. Methods: This case-control study consisted of 61 PCOS patients, and 35 women with normal ovulatory function served as controls. Bone parameters, including bone mineral content (BMC) and bone mineral density (BMD) in addition to T- and Z-scores, were measured at the lumbar vertebrae, neck of the left femur, hip, and distal part of the radial bone, using dual-energy X-ray absorptiometry. Blood samples were taken to be tested for biochemical parameters and serum concentrations of insulin, osteocalcin, parathyroid hormone (PTH), vitamin D, follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, dehydroepiandrosterone sulfate (DHEAS), and estradiol were measured. Insulin resistance was evaluated through the homeostatic model assessment of insulin resistance (HOMA-IR). Results: The results revealed greater levels of HOMA-IR and total testosterone in PCOS women than in controls. Nevertheless, the two groups were comparable in terms of bone parameters. In the control group, BMI was the only determinant of bone density at most of the skeletal sites. Nonetheless, BMI and HOMA-IR were independently and positively associated with bone indices at the femoral neck (FN) and total hip in the PCOS group. Parathyroid hormone and vitamin D concentrations were not different in the two groups. However, phosphate levels were higher in PCOS patients (P = 0.025). Osteocalcin was inversely correlated to BMI, and both groups had a negative correlation between DHEAS and PTH. Serum phosphate was inversely and independently associated with estrogen in the PCOS group (r = -0.377, P = 0.004). Conclusions: Body mass index and HOMA-IR were independent and positive determinants of FN and total hip bone density in the PCOS subjects. Nonetheless, in the non-PCOS women, BMI was the only independent determinant of bone density at most of the skeletal sites. Additionally, osteocalcin was inversely correlated with BMI in both groups.

Hyperhomocysteinemia, insulin resistance and body mass index in Iranian young women with polycystic ovary syndrome

Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population

Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine

Association Between Insulin Resistance Indices and Liver Function Parameters Among Women With Polycystic Ovary Syndrome

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome

Association of obesity and hyperandrogenemia with insulin resistance in women with polycystic ovary syndrome

Dyslipidemia in Relation to Body Mass Index and Insulin Resistance in Chinese Women with Polycystic Ovary Syndrome.

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients

Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome

Status of Homocysteine in Polycystic Ovary Syndrome (PCOS)

Serum Levels of Leptin and Homocysteine in Women with Polycystic Ovary Syndrome and Its Relationship to Endocrine, Clinical and Metabolic Parameters

Clinical study of insulin resistance in women with polycystic ovary syndrome

The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome

INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME IN A CHINESE POPULATION.

Endocrine and metabolizable characters of polycystic ovary syndrome patients

Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome

PCOS women show significantly higher homocysteine level, independent to glucose and E2 level

The Association Between Increment of Interleukin-1 and Interleukin-6 in Women with Polycystic Ovary Syndrome and Body Mass Index